任职于广州医科大学附属第一医院/广州呼吸健康研究院

中华医学会呼吸病学分会慢阻肺学组 秘书；广州市医师协会青年医师分会 常委；广州市高层次人才（青年后备）；《慢性阻塞性肺疾病诊治指南（2021年修订版）》专家组成员

1　广东省自然科学基金（广东省科技厅），2015A030310497，应用数据挖掘技术识别哮喘内因型的研究

2　广州市科技计划项目（广州市科技局），103270653062，基于机器学习的慢阻肺定量CT多维评价指标体系研究

[1] 　Liang Z, Zhong N, Chen R, Ma Q, Sun Y, Wen F, Tal-Singer R, Miller B E, Yates J, Song J, Compton C, Ji B, Wu L, Yang Y, Jones P, Zheng J. Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale[J]. ERJ Open Res,2021,7(3):00201.

[2] 　Chen Y J^#, Jian W H^#, Liang Z Y^#（共一）, Guan W J^#, Liang W H^#, Chen R C, Tang C L, Wang T, Liang H R, Li Y M, Liu X Q, Sang L, Cheng L L, Ye F, Li S Y, Zhang N F, Zhang Z, Fang Y, He J X, Zhong N S, Zheng J P. Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis[J]. Ann Transl Med,2021,9(11):941.

[3]　 Xu J^#, Liang Z^#（共一）, Jian W^#, Li J, Tang G, Mo X, Zhang D, Zheng J, Qian Y, Liu J, Li S. Changes of quantitative CT-based airway wall dimensions in patients with COVID-19 during early recovery[J]. J Thorac Dis,2021,13(3):1517-1530.

[4]　 Liang Z^#, Long F^#, Deng K^#, Wang F^#, Xiao J, Yang Y, Zhang D, Gu W, Xu J, Jian W, Shi W, Zheng J, Chen X, Gao Y, Luo Q, Stampfli M R, Peng T, Chen R. Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease[J]. Ann Transl Med,2020,8(15):918.

[5]　 Wang Z, Liu H, Wang F, Yang Y, Wang X, Chen B, Stampfli M R, Zhou H, Shu W, Brightling C E, Liang Z*（共同通讯）, Chen R*. A Refined View of Airway Microbiome in Chronic Obstructive Pulmonary Disease at Species and Strain-Levels[J]. Front Microbiol,2020,11:1758.

[6]　 Liang Z^#, Wang F^#, Zhang D^#, Long F^#, Yang Y^#, Gu W, Deng K, Xu J, Jian W, Zhou L, Shi W, Zheng J, Chen X, Chen R. Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammation[J]. J Thorac Dis,2020,12(6):3085-3100.

[7] 　Li R, Liu J, Fang Z, Liang Z*（共同通讯）, Chen X*. Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma[J]. Front Pharmacol,2020,11:572627.

[8]　Liang Z^#, Long F^#, Wang F^#, Yang Y, Xiao J, Deng K, Gu W, Zhou L, Xie J, Jian W, Chen X, Jiang M, Zheng J, Peng T, Chen R. Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles[J]. Mol Med Rep, 2019, 20(3):2882-2892.

[9] 　梁振宇，陈荣昌. 慢性阻塞性肺疾病诊疗指南（2021年修订版）修订历程及思考[J]. 中华结核和呼吸杂志,2021,44(3):165-166.

[10]　梁振宇，王凤燕，陈荣昌. 慢性阻塞性肺疾病诊治指南(2021年修订版)的重要更新解读及展望[J]. 国际呼吸杂志,2021,41(19):1457-1461.

[11] 　梁振宇，王凤燕，王凌伟，邱晨，陈荣昌. 2020版慢性阻塞性肺疾病全球创议新引用文献与更新的亮点解读[J]. 中华结核和呼吸杂志,2020,43(4):350-355.

[12] 　中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师协会呼吸医师分会慢阻肺工作委员会. 慢性阻塞性肺疾病诊治指南（2021年修订版）[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. （专家组成员）